A Simple Prognostic Score for Critical COVID-19 Derived from Patients without Comorbidities Performs Well in Unselected Patients

We aimed to search for laboratory predictors of critical COVID-19 in consecutive adults admitted in an academic center between 16 September 2020–20 December 2021. Patients were uniformly treated with low-molecular-weight heparin, and dexamethasone plus remdesivir when SpO2 < 94%. Among consecutive unvaccinated patients without underlying medical conditions (<i<n</i< = 241, 49 year-old median, 71% males), 22 (9.1%) developed critical disease and 2 died (0.8%). White-blood-cell counts, neutrophils, neutrophil-to-lymphocyte ratio, CRP, fibrinogen, ferritin, LDH and γ-GT at admission were each univariably associated with critical disease. ROC-defined cutoffs revealed that CRP < 61.8 mg/L, fibrinogen < 616.5 mg/dL and LDH < 380.5 U/L were each associated with critical disease development, independently of age, sex and days from symptom-onset. A score combining higher-than-cutoff CRP (0/2), LDH (0/1) and fibrinogen (0/1) predicted critical disease (AUC: 0.873, 95% CI: 0.820–0.926). This score performed well in an unselected patient cohort (<i<n</i< = 1228, 100% unvaccinated) predominantly infected by the alpha variant (AUC: 0.718, 95% CI: 0.683–0.753), as well as in a mixed cohort (<i<n</i< = 527, 65% unvaccinated) predominantly infected by the delta variant (AUC: 0.708, 95% CI: 0.656–0.760). Therefore, we propose that a combination of standard biomarkers of acute inflammatory response, cell death and hypercoagulability reflects the severity of COVID-19 per se independently of comorbidities, age and sex, being of value for risk stratification in unselected patients..

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:11

Enthalten in:

Journal of Clinical Medicine - 11(2022), 7, p 1810

Sprache:

Englisch

Beteiligte Personen:

Vasiliki E. Georgakopoulou [VerfasserIn]
Nikolaos I. Vlachogiannis [VerfasserIn]
Dimitrios Basoulis [VerfasserIn]
Irene Eliadi [VerfasserIn]
Georgios Georgiopoulos [VerfasserIn]
Georgios Karamanakos [VerfasserIn]
Sotiria Makrodimitri [VerfasserIn]
Stamatia Samara [VerfasserIn]
Maria Triantafyllou [VerfasserIn]
Pantazis M. Voutsinas [VerfasserIn]
Fotinie Ntziora [VerfasserIn]
Mina Psichogiou [VerfasserIn]
Michael Samarkos [VerfasserIn]
Petros P. Sfikakis [VerfasserIn]
Nikolaos V. Sipsas [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.mdpi.com [kostenfrei]
Journal toc [kostenfrei]

Themen:

COVID-19
Comorbidities
Critical disease
Medicine
Prognosis
R
Vaccination

doi:

10.3390/jcm11071810

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ001236261